Distributor inventory | Tablet
Glimepiride 2 mg + Metformin (as sustained/extended-release) 500 mg + Voglibose 0.2 mg
Type 2 diabetes mellitus in adults when blood sugar is not adequately controlled with diet, exercise and/or single/dual oral antidiabetic medicines; helps control post-meal and fasting glucose.
Glimepiride (a sulfonylurea) increases insulin release from the pancreas. Metformin reduces glucose production in the liver and improves insulin sensitivity. Voglibose (an alpha-glucosidase inhibitor) slows carbohydrate digestion in the gut, reducing post-meal blood sugar spikes.
Take exactly as prescribed. Usually taken once daily with the main meal (often breakfast) to reduce stomach side effects and risk of hypoglycaemia; swallow whole (do not crush/chew) especially if it is sustained/extended-release metformin. Monitor blood glucose regularly and follow diet/exercise advice.
Common side effects of VOLIX TRIO DS 2MG TAB may include:
Risk of hypoglycaemia (higher if meals are skipped, with alcohol, or with other antidiabetics); do not use in type 1 diabetes or diabetic ketoacidosis. Metformin may rarely cause lactic acidosis—risk increases with severe kidney disease, dehydration, severe infection, shock, heavy alcohol use; kidney function monitoring required. Use caution in liver disease, elderly, malnutrition, and in patients with adrenal/pituitary insufficiency. Temporarily stop metformin around iodinated contrast studies or major surgery as advised by doctor. Seek urgent care for symptoms of severe hypoglycaemia or lactic acidosis (rapid breathing, severe weakness, abdominal pain, confusion).
